Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Un écran d'ordinateur avec une image médicale

Bidding Program Big Brain Theory

Exploring new avenues

Last update: 28/02/2026 Reading time: 1min
Retour à la recherche

Launched in June 2015 by Paris Brain Institute, the Big Brain Theory (BBT) programme funds innovative, interdisciplinary, high-risk projects co-sponsored by various in-house research teams.

Origins of the programme

Origins of the programme

The Big Brain Theory program was born out of an original idea: what if it were possible to do research differently, more boldly and interdisciplinarily, to find tomorrow’s treatments for brain diseases?

Why "Big Brain"? Because the challenges of the brain are immense, and because so are our ambitions to serve patients.

Why “Theory”? Because we want to propose unexplored ideas and new ways to advance our understanding of our brain.

This research program now includes many bold and innovative projects, some of which have already led to major discoveries.

Exploring new avenues

Exploring new avenues

Since its inception, the Big Brain Theory program has provided grants for innovative, interdisciplinary new projects in neuroscience for researchers and clinicians at the Institute.

Paris Brain Institute hopes that each "Big Brain Theory" will aim to engage each Principal Investigator and Platforms in a collaborative effort to broaden the impact of individual-level research and develop new pioneering projects that translate into collective advances that will become the symbols of the Institute.

News that might interest you

Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
See all our news